Search Results

Displaying Results 1-2 of 2 "'PDSB'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

Jan 12, 2026, 10:35 ET Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

(NASDAQ: CGON), Zentalis Pharmaceuticals (NASDAQ: ZNTL), ArriVent BioPharma (NASDAQ: AVBP), and PDS Biotechnology (NASDAQ: PDSB).  

More news about: USA News Group

Biotech Stocks Rally as Oncology Market Targets $866B by 2034

Aug 14, 2025, 12:30 ET Biotech Stocks Rally as Oncology Market Targets $866B by 2034

PRPH), IO Biotech, Inc. (NASDAQ: IOBT), Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), and PDS Biotechnology Corporation (NASDAQ: PDSB).

More news about: Equity Insider

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.